These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6054779)

  • 1. The amphetamines.
    Swanton C
    Med J Aust; 1967 Sep; 2(13):625. PubMed ID: 6054779
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of wekamines on humans].
    Sloot HA
    Pharm Weekbl; 1969 Aug; 104(35):1075-8. PubMed ID: 5806269
    [No Abstract]   [Full Text] [Related]  

  • 3. A survey of the usage of amphetamines in parts of the Sydney community.
    Kneebone GM
    Med J Aust; 1968 Aug; 2(5):246. PubMed ID: 5676212
    [No Abstract]   [Full Text] [Related]  

  • 4. A survey of the usage of amphetamines in parts of the Sidney community.
    De Groot JC
    Med J Aust; 1968 May; 1(19):826. PubMed ID: 5656962
    [No Abstract]   [Full Text] [Related]  

  • 5. Control of amphetamine preparations.
    Br Med J; 1968 Nov; 4(5630):572-3. PubMed ID: 5722324
    [No Abstract]   [Full Text] [Related]  

  • 6. PATTERNS OF HALLUCINOGENIC DRUG ABUSE.
    LUDWIG AM; LEVINE J
    JAMA; 1965 Jan; 191():92-6. PubMed ID: 14233246
    [No Abstract]   [Full Text] [Related]  

  • 7. The amphetamine blues.
    DeKornfeld TJ
    Mich Med; 1987 Sep; 86(9):606, 608, 610. PubMed ID: 3454864
    [No Abstract]   [Full Text] [Related]  

  • 8. Amphetamines and their derivatives.
    Haynes WS
    Med J Aust; 1970 Mar; 1(11):566. PubMed ID: 5443517
    [No Abstract]   [Full Text] [Related]  

  • 9. Control of amphetamines in the Republic of Ireland.
    Timoney RF
    J Ir Med Assoc; 1972 Feb; 65(3):57-61. PubMed ID: 5060442
    [No Abstract]   [Full Text] [Related]  

  • 10. Voluntary restriction of amphetamines.
    Br Med J; 1968 Nov; 4(5630):532-3. PubMed ID: 5722312
    [No Abstract]   [Full Text] [Related]  

  • 11. [Problems with narcotics].
    Siegenthaler G
    SSO Schweiz Monatsschr Zahnheilkd; 1971 Nov; 81(11):1132-8. PubMed ID: 5290004
    [No Abstract]   [Full Text] [Related]  

  • 12. A San Francisco Bay Area "speed" scene.
    Carey JT; Mandel J
    J Health Soc Behav; 1968 Jun; 9(2):164-74. PubMed ID: 5745773
    [No Abstract]   [Full Text] [Related]  

  • 13. Control of amphetamines and L.S.D.
    Lancet; 1970 Apr; 1(7649):708. PubMed ID: 4191006
    [No Abstract]   [Full Text] [Related]  

  • 14. An argument for permitting amphetamines and instant-release methylphenidate.
    Flanigan J
    Am J Bioeth; 2013; 13(7):49-51. PubMed ID: 23767443
    [No Abstract]   [Full Text] [Related]  

  • 15. The uses and misuses of amphetamines.
    Salsbury CA; Wayland RB
    Med Leg Bull; 1966 Apr; 15(4):1-9. PubMed ID: 5932326
    [No Abstract]   [Full Text] [Related]  

  • 16. Prohibition or coffee shops: regulation of amphetamine and methylphenidate for enhancement use by healthy adults.
    Dubljević V
    Am J Bioeth; 2013; 13(7):23-33. PubMed ID: 23767434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of the stimulant addiction problem.
    Med J Aust; 1969 Nov; 2(21):1036-7. PubMed ID: 5373729
    [No Abstract]   [Full Text] [Related]  

  • 18. Anaphylaxis following amphetamines.
    Fellner MJ; Oppenheim M
    Acta Derm Venereol; 1972; 52(1):49-50. PubMed ID: 4111106
    [No Abstract]   [Full Text] [Related]  

  • 19. The adverse effects of amphetamines.
    Hart JB; Wallace J
    Clin Toxicol; 1975; 8(2):179-90. PubMed ID: 1149409
    [No Abstract]   [Full Text] [Related]  

  • 20. Sensitization to amphetamines.
    Wallach MB; Gershon S
    Psychopharmacol Bull; 1971 Oct; 7(4):30-1. PubMed ID: 5165643
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.